Impact of acellular hemoglobin-based oxygen carriers on brain apoptosis in rats

Transfusion

Volumn 54, Issue 8, 2014, Pages 2045-2054

  Vandegriff, Kim D ^a   Malavalli, Ashok ^a   Lohman, Jeff ^a   Young, Mark A ^a   Terraneo, Laura ^b   Virgili, Eleonora ^b   Bianciardi, Paola ^b   Caretti, Anna ^b   Samaja, Michele ^b  

^a SANGART INC   (United States)

^b SAN PAOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DNA NUCLEOTIDYLEXOTRANSFERASE; HEMOGLOBIN; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN BASED OXYGEN CARRIER; HETASTARCH; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; POLYMERIZED HEMOGLOBIN; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD; BLOOD VOLUME; BRAIN TISSUE; CELL PROTECTION; COLLOID; CONTROLLED STUDY; EUTHANASIA; EXCHANGE BLOOD TRANSFUSION; HEMODILUTION; NERVE CELL LESION; NERVE CELL NECROSIS; NONHUMAN; OXIDATIVE STRESS; OXYGEN AFFINITY; OXYGEN TRANSPORT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RESUSCITATION; TISSUE INJURY;

ANIMALS; APOPTOSIS; ASPIRIN; BLOOD SUBSTITUTES; BRAIN; CELL HYPOXIA; DRUG EVALUATION, PRECLINICAL; EXCHANGE TRANSFUSION, WHOLE BLOOD; HEMODILUTION; HEMOGLOBINS; HEMORRHAGE; HYDROXYETHYL STARCH DERIVATIVES; HYPOXIA, BRAIN; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALEIMIDES; NERVE TISSUE PROTEINS; NEURONS; OXYGEN; POLYETHYLENE GLYCOLS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84906248649     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12643     Document Type: Article

References (48)

1. Hartog CS, Kohl M, Reinhart K,. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg 2011; 112: 635-645.
2. Sloan EP, Koenigsberg M, Gens D, et al. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA 1999; 282: 1857-1864.
3. Mollan TL, Alayash AI,. Redox reactions of hemoglobin: mechanisms of toxicity and control. Antioxid Redox Signal 2013; 18: 2251-2253.
4. Vandegriff KD, Malavalli A, Wooldridge J, et al. MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion 2003; 43: 509-516.
5. 2 binding to a maleimide poly(ethylene glycol)-conjugated human haemoglobin. Biochem J 2004; 382: 183-189.
6. Svergun DI, Ekström F, Vandegriff KD, et al. Solution structure of poly(ethylene) glycol-conjugated hemoglobin revealed by small-angle X-ray scattering: implications for a new oxygen therapeutic. Biophys J 2008; 94: 173-181.
7. Young MA, Riddez L, Kjellström BT, et al. Effect of maleimide-polyethylene glycol hemoglobin (MP4) on hemodynamics and acid-base status after uncontrolled hemorrhage in anesthetized swine: comparison with crystalloid and blood. J Trauma 2007; 63: 1234-1244.
8. 2 therapeutics. Am J Physiol Heart Circ Physiol 2003; 285: H1411-1419.
9. Young MA, Lohman J, Malavalli A, et al. Hemospan improves outcome in a model of perioperative hemodilution and blood loss in the rat: comparison with hydroxyethyl starch. J Cardiothorac Vasc Anesth 2009; 23: 339-347.
10. Young MA, Riddez L, Kjellström BT, et al. MalPEG-hemoglobin (MP4) improves hemodynamics, acid-base status, and survival after uncontrolled hemorrhage in anesthetized swine. Crit Care Med 2005; 33: 1794-1804.
11. Winslow RM, Gonzales A, Gonzales ML, et al. Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model. J Appl Physiol 1998; 85: 993-1003.
12. Manalo DJ, Rowan A, Lavoie T, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005; 105: 659-669.
13. Mintun MA, Lundstrom BN, Snyder AZ, et al. Blood flow and oxygen delivery to human brain during functional activity: theoretical modeling and experimental data. Proc Natl Acad Sci U S A 2001; 98: 6859-6864.
14. Ulatowski JA, Bucci E, Razynska A, et al. Cerebral blood flow during hypoxic hypoxia with plasma-based hemoglobin at reduced hematocrit. Am J Physiol 1998; 274: H1933-1942.
15. Mongan PD, Moon-Massat PF, Rentko V, et al. Regional blood flow after serial normovolemic exchange transfusion with HBOC-201 (Hemopure) in anesthetized swine. J Trauma 2009; 67: 51-60.
16. Butt OI, Buehler PW, D'Agnillo F,. Blood-brain barrier disruption and oxidative stress in guinea pig after systemic exposure to modified cell-free hemoglobin. Am J Pathol 2011; 178: 1316-1328.
17. Samaja M, Terraneo L,. Impact of hemoglobin concentration and affinity for oxygen on tissue oxygenation: the case of hemoglobin-based oxygen carriers. Artif Organs 2011; 36: 210-223.
18. Caretti A, Morel S, Milano G, et al. Heart HIF-1alpha and MAP kinases during hypoxia: are they associated in vivo? Exp Biol Med 2007; 232: 887-894.
19. Vandegriff KD, Malavalli A, Minn C, et al. Oxidation and haem loss kinetics of poly(ethylene glycol)-conjugated haemoglobin (MP4): dissociation between in vitro and in vivo oxidation rates. Biochem J 2006; 399: 463-471.
20. Keipert PE, Gomez CL, Gonzales A, et al. Diaspirin cross-linked hemoglobin: tissue distribution and long-term excretion after exchange transfusion. J Lab Clin Med 1994; 123: 701-711.
21. Ratan RR, Siddiq A, Smirnova N, et al. Harnessing hypoxic adaptation to prevent, treat, and repair stroke. J Mol Med (Berl) 2007; 85: 1331-1338.
22. Baranova O, Miranda LF, Pichiule P, et al. Neuron-specific inactivation of the hypoxia inducible factor 1alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci 2007; 27: 6320-6332.
23. Kilic E, Kilic U, Wang Y, et al. The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J 2006; 20: 1185-1187.
24. Ghezzi P, Brines M,. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 2004; 11 (Suppl 1): S37-44.
25. Choksi S, Lin Y, Pobezinskaya Y, et al. A HIF-1 target, ATIA, protects cells from apoptosis by modulating the mitochondrial thioredoxin, TRX2. Mol Cell 2011; 42: 597-609.
26. Chen C, Hu Q, Yan J, et al. Early inhibition of HIF-1alpha with small interfering RNA reduces ischemic-reperfused brain injury in rats. Neurobiol Dis 2009; 33: 509-517.
27. Helton R, Cui J, Scheel JR, et al. Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage. J Neurosci 2005; 25: 4099-4107.
28. Zhong H, Chiles K, Feldser D, et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 2000; 60: 1541-1545.
29. Li F, Sonveaux P, Rabbani ZN, et al. Regulation of HIF-1alpha stability through S-nitrosylation. Mol Cell 2007; 26: 63-74.
30. Kasuno K, Takabuchi S, Fukuda K, et al. Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signaling. J Biol Chem 2004; 279: 2550-2558.
31. Metzen E, Zhou J, Jelkmann W, et al. Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Mol Biol Cell 2003; 14: 3470-3481.
32. Hagen T, Taylor CT, Lam F, et al. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science 2003; 302: 1975-1978.
33. Vangeison G, Carr D, Federoff HJ, et al. The good, the bad, and the cell type-specific roles of hypoxia inducible factor-1 alpha in neurons and astrocytes. J Neurosci 2008; 28: 1988-1993.
34. Yeh LH, Alayash AI,. Effects of cell-free hemoglobin on hypoxia-inducible factor (HIF-1alpha) and heme oxygenase (HO-1) expressions in endothelial cells subjected to hypoxia. Antioxid Redox Signal 2004; 6: 944-953.
35. Buehler PW, D'Agnillo F, Hoffman V, et al. Effects of endogenous ascorbate on oxidation, oxygenation, and toxicokinetics of cell-free modified hemoglobin after exchange transfusion in rat and guinea pig. J Pharmacol Exp Ther 2007; 323: 49-60.
36. Manalo DJ, Buehler PW, Baek JH, et al. Acellular haemoglobin attenuates hypoxia-inducible factor-1alpha (HIF-1alpha) and its target genes in haemodiluted rats. Biochem J 2008; 414: 461-469.
37. Sussman MA, Volkers M, Fischer K, et al. Myocardial AKT: the omnipresent nexus. Physiol Rev 2011; 91: 1023-1070.
38. Milano G, Bianciardi P, Rochemont V, et al. Phosphodiesterase-5 inhibition mimics intermittent reoxygenation and improves cardioprotection in the hypoxic myocardium. Plos ONE 2011; 6: e27910.
39. Milano G, von Segesser LK, Morel S, et al. Phosphorylation of phosphatidylinositol-3-kinase-protein kinase B and extracellular signal-regulated kinases 1/2 mediate reoxygenation-induced cardioprotection during hypoxia. Exp Biol Med 2010; 235: 401-410.
40. Caretti A, Bianciardi P, Ronchi R, et al. Phosphodiesterase-5 inhibition abolishes neuron apoptosis induced by chronic hypoxia independently of hypoxia-inducible factor-1alpha signaling. Exp Biol Med 2008; 233: 1222-1230.
41. McNamara CR, Degterev A,. Small-molecule inhibitors of the PI3K signaling network. Future Med Chem 2011; 3: 549-565.
42. Zhu YM, Wang CC, Chen L, et al. Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats. Brain Res 2013; 1494: 1-8.
43. Gao X, Zhang H, Steinberg G, et al. The Akt pathway is involved in rapid ischemic tolerance in focal ischemia in rats. Transl Stroke Res 2010; 1: 202-209.
44. Nakajima T, Iwabuchi S, Miyazaki H, et al. Preconditioning prevents ischemia-induced neuronal death through persistent Akt activation in the penumbra region of the rat brain. J Vet Med Sci 2004; 66: 521-527.
45. Wang C, Wang Z, Zhang X, et al. Protection by silibinin against experimental ischemic stroke: up-regulated pAkt, pmTOR, HIF-1alpha and Bcl-2, down-regulated Bax, NF-kappaB expression. Neurosci Lett 2012; 529: 45-50.
46. Wick A, Wick W, Waltenberger J, et al. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci 2002; 22: 6401-6407.
47. Olsen S, Malavalli A, Vandegriff K,. Correlation between hemoglobin oxygen affinity and nitrite reductase activity. FASEB J 2012; 26: A573.
48. Pichiule P, Agam F, Chavez JC, et al. HIF-1 alpha and VEGF expression after transient global cerebral ischemia. Adv Exp Med Biol 2003; 530: 611-617.